Ten-year outcomes after DMEK, DSAEK, and PK: insights on graft survival, endothelial cell density loss, rejection and visual acuity
- PMID: 39774993
- PMCID: PMC11707042
- DOI: 10.1038/s41598-025-85138-4
Ten-year outcomes after DMEK, DSAEK, and PK: insights on graft survival, endothelial cell density loss, rejection and visual acuity
Abstract
Fuchs Endothelial Corneal Dystrophy (FECD) is the most frequent indication for corneal transplantation, with Descemet membrane endothelial keratoplasty (DMEK), Descemet stripping automated endothelial keratoplasty (DSAEK), and penetrating keratoplasty (PK) being viable options. This retrospective study compared 10-year outcomes of these techniques in a large cohort of 2956 first-time keratoplasty eyes treated for FECD at a high-volume corneal transplant center in Germany. While DMEK and DSAEK provided faster visual recovery (median time to BSCVA ≥ 6/12 Snellen: DMEK 7.8 months, DSAEK 12.4 months, PK 37.9 months; cumulative probability of BSCVA ≥ 6/12 Snellen within 5 years: DMEK 93%, DSAEK 83%, PK 63%), PK surprisingly exhibited superior long-term graft survival (92% vs. 75% for DMEK and 73% for DSAEK at 10 years). Endothelial cell density (ECD) decreased significantly faster after DMEK and DSAEK, potentially contributing to their lower graft survival (10-year ECD > 1000 cells/mm2 probability: DMEK 3%, DSAEK 8%, PK 18%). DMEK demonstrated the lowest rejection rate (10% at 10 years vs. 13% for PK and 19% for DSAEK). These findings challenge the perceived superiority of endothelial keratoplasty and highlight the need for further investigation into the long-term implications of accelerated endothelial cell loss after DMEK and DSAEK.
Keywords: Corneal transplantation; DMEK; DSAEK; Fuchs endothelial corneal dystrophy; Graft survival; Penetrating keratoplasty.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Generative AI and AI-assisted technologies in the writing process: Grammarly v1.72.3.0, DeepL, GPT-4o, and Claude 3.5 Sonnet were used for linguistic improvements. The authors carefully checked the text suggestions for accuracy and made corrections where necessary. They take full responsibility for the publication’s content.
Figures









Similar articles
-
Descemet Membrane Endothelial Keratoplasty Versus Descemet Stripping Automated Endothelial Keratoplasty and Penetrating Keratoplasty.Am J Ophthalmol. 2019 Nov;207:288-303. doi: 10.1016/j.ajo.2019.06.012. Epub 2019 Jun 19. Am J Ophthalmol. 2019. PMID: 31228467
-
Outcomes of Descemet membrane endothelial keratoplasty, Descemet stripping automated endothelial keratoplasty and penetrating keratoplasty from a single centre study.Graefes Arch Clin Exp Ophthalmol. 2016 Mar;254(3):515-22. doi: 10.1007/s00417-015-3248-z. Epub 2016 Jan 7. Graefes Arch Clin Exp Ophthalmol. 2016. PMID: 26743748
-
Descemet Membrane Endothelial Keratoplasty versus Ultrathin Descemet Stripping Automated Endothelial Keratoplasty: A Multicenter Randomized Controlled Clinical Trial.Ophthalmology. 2020 Sep;127(9):1152-1159. doi: 10.1016/j.ophtha.2020.02.029. Epub 2020 Mar 2. Ophthalmology. 2020. PMID: 32386811 Clinical Trial.
-
Comparison of DMEK and DSAEK in Eyes With Endothelial Decompensation After Previous Penetrating Keratoplasty.Cornea. 2021 Sep 1;40(9):1218-1224. doi: 10.1097/ICO.0000000000002786. Cornea. 2021. PMID: 34116539 Review.
-
Long-term Outcomes After Lamellar Endothelial Keratoplasty Compared With Penetrating Keratoplasty for Corneal Endothelial Dysfunction: A Systematic Review.Cornea. 2023 Jul 1;42(7):917-928. doi: 10.1097/ICO.0000000000003240. Epub 2023 Apr 25. Cornea. 2023. PMID: 37185592
Cited by
-
Review of the Literature: Surgery Indications for Fuchs' Endothelial Corneal Dystrophy.J Clin Med. 2025 Mar 29;14(7):2365. doi: 10.3390/jcm14072365. J Clin Med. 2025. PMID: 40217815 Free PMC article. Review.
-
Non-Descemet Stripping Automated Endothelial Keratoplasty (nDSAEK) for Late Endothelial Failure After Mushroom Keratoplasty: A Retrospective Analysis of Visual and Anatomical Outcomes.J Clin Med. 2025 Aug 7;14(15):5568. doi: 10.3390/jcm14155568. J Clin Med. 2025. PMID: 40807189 Free PMC article.
-
A Review of Outcomes of Descemet Membrane Endothelial Keratoplasty and Descemet Stripping Automated Endothelial Keratoplasty Interventions in Patients with Pre-Existing Glaucoma.J Clin Med. 2025 May 18;14(10):3534. doi: 10.3390/jcm14103534. J Clin Med. 2025. PMID: 40429529 Free PMC article. Review.
References
-
- Gain, P. et al. Global survey of corneal transplantation and eye banking. JAMA Ophthalmol.134, 167. 10.1001/jamaophthalmol.2015.4776 (2016). - PubMed
-
- Altamirano, F. et al. fuchs endothelial corneal dystrophy: An updated review. Int. Ophthalmol.44, 61. 10.1007/s10792-024-02994-1 (2024). - PubMed
-
- Melles, G. R. J., Ong, T. S., Ververs, B. & van der Wees, J. Descemet membrane endothelial keratoplasty (DMEK). Cornea25, 987–990. 10.1097/01.ico.0000248385.16896.34 (2006). - PubMed
-
- Sarnicola, C., Farooq, A. V. & Colby, K. Fuchs endothelial corneal dystrophy: Update on pathogenesis and future directions. Eye Contact Lens Sci. Clin. Pract.45, 1–10. 10.1097/ICL.0000000000000469 (2019). - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources